Winslow Evans & Crocker’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | $106K | Buy |
1,121
+204
| +22% | +$19.3K | 0.02% | 427 |
|
|
2020
Q3 | $79K | Buy |
917
+441
| +93% | +$38K | 0.02% | 389 |
|
|
2020
Q2 | $42K | Hold |
476
| – | – | 0.01% | 489 |
|
|
2020
Q1 | $40K | Sell |
476
-612
| -56% | -$51.4K | 0.01% | 463 |
|
|
2019
Q4 | $106K | Hold |
1,088
| – | – | 0.03% | 388 |
|
|
2019
Q3 | $98K | Buy |
1,088
+4
| +0.4% | +$360 | 0.03% | 402 |
|
|
2019
Q2 | $102K | Buy |
1,084
+1
| +0.1% | +$94 | 0.03% | 398 |
|
|
2019
Q1 | $96K | Buy |
1,083
+438
| +68% | +$38.8K | 0.03% | 388 |
|
|
2018
Q4 | $52K | Sell |
645
-25
| -4% | -$2.02K | 0.02% | 453 |
|
|
2018
Q3 | $54K | Hold |
670
| – | – | 0.02% | 471 |
|
|
2018
Q2 | $46K | Hold |
670
| – | – | 0.01% | 513 |
|
|
2018
Q1 | $48.5K | Hold |
670
| – | – | 0.02% | 485 |
|
|
2017
Q4 | $50.4K | Hold |
670
| – | – | 0.02% | 489 |
|
|
2017
Q3 | $51.5K | Sell |
670
-281
| -30% | -$21.6K | 0.02% | 470 |
|
|
2017
Q2 | $71.1K | Sell |
951
-390
| -29% | -$29.2K | 0.02% | 483 |
|
|
2017
Q1 | $89.3K | Hold |
1,341
| – | – | 0.03% | 435 |
|
|
2016
Q4 | $87.6K | Sell |
1,341
-103
| -7% | -$6.73K | 0.03% | 428 |
|
|
2016
Q3 | $102K | Hold |
1,444
| – | – | 0.03% | 402 |
|
|
2016
Q2 | $107K | Hold |
1,444
| – | – | 0.03% | 368 |
|
|
2016
Q1 | $93.7K | Sell |
1,444
-112
| -7% | -$7.27K | 0.03% | 378 |
|
|
2015
Q4 | $120K | Sell |
1,556
-183
| -11% | -$14.1K | 0.03% | 365 |
|
|
2015
Q3 | $143K | Hold |
1,739
| – | – | 0.05% | 336 |
|
|
2015
Q2 | $153K | Buy |
1,739
+87
| +5% | +$7.67K | 0.04% | 356 |
|
|
2015
Q1 | $146K | Sell |
1,652
-263
| -14% | -$23.2K | 0.04% | 349 |
|
|
2014
Q4 | $159K | Sell |
1,915
-201
| -9% | -$16.7K | 0.05% | 320 |
|
|
2014
Q3 | $178K | Buy |
2,116
+203
| +11% | +$17.1K | 0.05% | 321 |
|
|
2014
Q2 | $155K | Hold |
1,913
| – | – | 0.05% | 296 |
|
|
2014
Q1 | $146K | Sell |
1,913
-197
| -9% | -$15K | 0.05% | 301 |
|
|
2013
Q4 | $152K | Buy |
+2,110
| New | +$152K | 0.05% | 309 |
|